KIF18B is a Prognostic Biomarker and Correlates with Immune Infiltrates in Pan-Cancer
Background: Cancer is one of the deadliest diseases at present. Although effective screening and treatment can save lives to a certain extent, our knowledge of the disease is far from sufficient. KIF18B is a member of the kinesin-8 superfamily and plays a conserved regulatory role in the cell cycle....
Main Authors: | Meng-jun Qiu, Qiu-shuang Wang, Qiu-ting Li, Li-sheng Zhu, Ya-nan Li, Sheng-li Yang, Zhi-fan Xiong |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-05-01
|
Series: | Frontiers in Molecular Biosciences |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmolb.2021.559800/full |
Similar Items
-
Prognostic Biomarker KIF18A and Its Correlations With Immune Infiltrates and Mitosis in Glioma
by: Bing-Yan Tao, et al.
Published: (2022-05-01) -
Comprehensive Pan-Cancer Analysis of KIF18A as a Marker for Prognosis and Immunity
by: Ting Liu, et al.
Published: (2023-02-01) -
Silencing KIF18B enhances radiosensitivity: identification of a promising therapeutic target in sarcoma
by: Wensi Liu, et al.
Published: (2020-11-01) -
KIF11 Serves as an Independent Prognostic Factor and Therapeutic Target for Patients With Lung Adenocarcinoma
by: Zhaodong Li, et al.
Published: (2021-04-01) -
KIF2C is a prognostic biomarker associated with immune cell infiltration in breast cancer
by: Shanshan Liu, et al.
Published: (2023-04-01)